XML 53 R44.htm IDEA: XBRL DOCUMENT
v3.23.3

Description of Business (Details) $ in Millions | 3 Months Ended | 9 Months Ended |
--- | --- | --- | ---
Sep. 30, 2023 USD ($) | Sep. 30, 2023 USD ($) product item | Dec. 31, 2022 USD ($)
Description of Business [Line Items] |  |  |
Proceeds from partial sale of interests in consolidated subsidiaries |  | $ 158 |
Icahn Enterprises Holdings |  |  |
Description of Business [Line Items] |  |  |
Percentage of equity ownership in operating subsidiary |  | 99.00% |
Icahn Enterprises Holdings | Icahn Enterprises G.P. |  |  |
Description of Business [Line Items] |  |  |
General partner ownership percentage in Icahn Enterprises |  | 1.00% |
Icahn Enterprises Holdings | Mr. Icahn and affiliates |  |  |
Description of Business [Line Items] |  |  |
Affiliate ownership interest |  | 85.00% |
Icahn Enterprises G.P. |  |  |
Description of Business [Line Items] |  |  |
Aggregate general partner ownership interest of parent and operating subsidiary |  | 1.99% |
CVR Refining |  |  |
Description of Business [Line Items] |  |  |
Percentage of equity ownership in operating subsidiary |  | 37.00% |
CVR Energy | Energy Segment |  |  |
Description of Business [Line Items] |  |  |
Percentage of equity ownership in operating subsidiary |  | 66.00% |
Viskase | Private Placement |  |  |
Description of Business [Line Items] |  |  |
Percentage of equity ownership in operating subsidiary |  | 90.00% |
Investment Funds |  |  |
Description of Business [Line Items] |  |  |
Fair value of investment in subsidiary | $ 3,600 | $ 3,600 | $ 4,200
CVR Partners | CVR Energy |  |  |
Description of Business [Line Items] |  |  |
Percentage of equity ownership in operating subsidiary |  | 100.00% |
CVR Energy | Energy Segment |  |  |
Description of Business [Line Items] |  |  |
Proceeds from partial sale of interests in consolidated subsidiaries | $ 158 |  |
Vivus | Pharma Segment |  |  |
Description of Business [Line Items] |  |  |
Number of approved therapies | item |  | 2 |
Number of product candidates in active clinical development | product |  | 2 |

X
- Definition [Line Items] for Description of Business + References No definition available. + Details
Name: | iep_DescriptionofBusinessLineItems
Namespace Prefix: | iep_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Aggregate Ownership interest of Parent and Holding Company Subsidiaries + References No definition available. + Details
Name: | iep_LimitedLiabilityCompanyLlcOrLimitedPartnershipLpManagingMemberOrGeneralPartnerAggregateOwnershipInterestOfParentAndHoldingCompanySubsidiaries
Namespace Prefix: | iep_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the number of approved therapies. + References No definition available. + Details
Name: | iep_NumberOfApprovedTherapies
Namespace Prefix: | iep_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of product candidate in active clinical development. + References No definition available. + Details
Name: | iep_NumberOfProductCandidateInActiveClinicalDevelopment
Namespace Prefix: | iep_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value of investment held in the subsidiary investment funds by the limited liability company or limited partnership. + References No definition available. + Details
Name: | iep_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterestFairValue
Namespace Prefix: | iep_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 272 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482987/272-10-50-3 + Details
Name: | us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 272 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482987/272-10-50-3 + Details
Name: | us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or sale of an entity that is related to it but not strictly controlled. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12 + Details
Name: | us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of units or percentage investment held in the subsidiary by the limited liability company or limited partnership. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_OwnershipAxis=iep_IcahnEnterprisesHoldingsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | iep_MembersOrPartnersAxis=iep_IcahnEnterprisesGPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | iep_MembersOrPartnersAxis=iep_PrincipalOwnersAndAffiliatesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=iep_IcahnEnterprisesGPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=iep_CvrRefiningLpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=iep_CvrEnergyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=iep_EnergySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=iep_ViskaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=iep_InvestmentFundsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=iep_CvrPartnersLpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=iep_CvrEnergyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=iep_VivusMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=iep_PharmaSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |